Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension
- Autores
- González, Germán Esteban; Rhaleb, N.-E.; D'Ambrosio, Martin A.; Nakagawa, Pablo; Liao, Tang Dong; Peterson, Edward L.; Leung, Pablo; Dai, Xiangguo; Janic, Branislava; Liu, Yun He; Yang, Xiao Ping; Carretero, Oscar A.
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Galectin- 3 (Gal-3), a member of the β-galactoside lectin family, has an important role in immune regulation. In hypertensive rats and heart failure patients, Gal-3 is considered a marker for an unfavorable prognosis. Nevertheless, the role and mechanism of Gal-3 action in hypertension-induced target organ damage are unknown. We hypothesized that, in angiotensin II (ANG II)-induced hypertension, genetic deletion of Gal-3 prevents left ventricular (LV) adverse remodeling and LV dysfunction by reducing the innate immune responses and myocardial fibrosis. To induce hypertension, male C57BL/6J and Gal-3 knockout (KO) mice were infused with ANG II (3 µg·min-1·kg-1 sc) for 8 wk. We assessed: 1) systolic blood pressure by plethysmography, 2) LV function and remodeling by echocardiography, 3) myocardial fibrosis by histology, 4) cardiac CD68+ macrophage infiltration by histology, 5) ICAM-1 and VCAM-1 expression by Western blotting, 6) plasma cytokines, including interleukin- 6 (IL-6), by enzyme-linked immunosorbent assay, and 7) regulatory T (Treg) cells by flow cytometry as detected by their combined expression of CD4, CD25, and FOXP3. Systolic blood pressure and cardiac hypertrophy increased similarly in both mouse strains when infused with ANG II. However, hypertensive C57BL/6J mice suffered impaired ejection and shortening fractions. In these mice, the extent of myocardial fibrosis and macrophage infiltration was greater in histological sections, and cardiac ICAM-1, as well as plasma IL-6, expression was higher as assessed by Western blotting. However, all these parameters were blunted in Gal-3 KO mice. Hypertensive Gal-3 KO mice also had a higher number of splenic Treg lymphocytes. In conclusion, in ANG II-induced hypertension, genetic deletion of Gal-3 prevented LV dysfunction without affecting blood pressure or LV hypertrophy. This study indicates that the ANG II effects are, in part, mediated or triggered by Gal-3 together with the related intercellular signaling (ICAM-1 and IL-6), leading to cardiac inflammation and fibrosis.
Fil: González, Germán Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Henry Ford Hospital; Estados Unidos
Fil: Rhaleb, N.-E.. Henry Ford Hospital; Estados Unidos. Wayne State University; Estados Unidos
Fil: D'Ambrosio, Martin A.. Henry Ford Hospital; Estados Unidos
Fil: Nakagawa, Pablo. Henry Ford Hospital; Estados Unidos
Fil: Liao, Tang Dong. Henry Ford Hospital; Estados Unidos
Fil: Peterson, Edward L.. Henry Ford Hospital; Estados Unidos
Fil: Leung, Pablo. Henry Ford Hospital; Estados Unidos
Fil: Dai, Xiangguo. Henry Ford Hospital; Estados Unidos
Fil: Janic, Branislava. Henry Ford Hospital; Estados Unidos
Fil: Liu, Yun He. Henry Ford Hospital; Estados Unidos
Fil: Yang, Xiao Ping. Henry Ford Hospital; Estados Unidos
Fil: Carretero, Oscar A.. Henry Ford Hospital; Estados Unidos - Materia
-
ANGIOTENSIN II
FIBROSIS
GALECTIN-3
HYPERTENSION
INFLAMMATION
INTERLEUKIN-6
MACROPHAGES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/86090
Ver los metadatos del registro completo
id |
CONICETDig_d72660733358070cc375f7ae8c21c831 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/86090 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertensionGonzález, Germán EstebanRhaleb, N.-E.D'Ambrosio, Martin A.Nakagawa, PabloLiao, Tang DongPeterson, Edward L.Leung, PabloDai, XiangguoJanic, BranislavaLiu, Yun HeYang, Xiao PingCarretero, Oscar A.ANGIOTENSIN IIFIBROSISGALECTIN-3HYPERTENSIONINFLAMMATIONINTERLEUKIN-6MACROPHAGEShttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Galectin- 3 (Gal-3), a member of the β-galactoside lectin family, has an important role in immune regulation. In hypertensive rats and heart failure patients, Gal-3 is considered a marker for an unfavorable prognosis. Nevertheless, the role and mechanism of Gal-3 action in hypertension-induced target organ damage are unknown. We hypothesized that, in angiotensin II (ANG II)-induced hypertension, genetic deletion of Gal-3 prevents left ventricular (LV) adverse remodeling and LV dysfunction by reducing the innate immune responses and myocardial fibrosis. To induce hypertension, male C57BL/6J and Gal-3 knockout (KO) mice were infused with ANG II (3 µg·min-1·kg-1 sc) for 8 wk. We assessed: 1) systolic blood pressure by plethysmography, 2) LV function and remodeling by echocardiography, 3) myocardial fibrosis by histology, 4) cardiac CD68+ macrophage infiltration by histology, 5) ICAM-1 and VCAM-1 expression by Western blotting, 6) plasma cytokines, including interleukin- 6 (IL-6), by enzyme-linked immunosorbent assay, and 7) regulatory T (Treg) cells by flow cytometry as detected by their combined expression of CD4, CD25, and FOXP3. Systolic blood pressure and cardiac hypertrophy increased similarly in both mouse strains when infused with ANG II. However, hypertensive C57BL/6J mice suffered impaired ejection and shortening fractions. In these mice, the extent of myocardial fibrosis and macrophage infiltration was greater in histological sections, and cardiac ICAM-1, as well as plasma IL-6, expression was higher as assessed by Western blotting. However, all these parameters were blunted in Gal-3 KO mice. Hypertensive Gal-3 KO mice also had a higher number of splenic Treg lymphocytes. In conclusion, in ANG II-induced hypertension, genetic deletion of Gal-3 prevented LV dysfunction without affecting blood pressure or LV hypertrophy. This study indicates that the ANG II effects are, in part, mediated or triggered by Gal-3 together with the related intercellular signaling (ICAM-1 and IL-6), leading to cardiac inflammation and fibrosis.Fil: González, Germán Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Henry Ford Hospital; Estados UnidosFil: Rhaleb, N.-E.. Henry Ford Hospital; Estados Unidos. Wayne State University; Estados UnidosFil: D'Ambrosio, Martin A.. Henry Ford Hospital; Estados UnidosFil: Nakagawa, Pablo. Henry Ford Hospital; Estados UnidosFil: Liao, Tang Dong. Henry Ford Hospital; Estados UnidosFil: Peterson, Edward L.. Henry Ford Hospital; Estados UnidosFil: Leung, Pablo. Henry Ford Hospital; Estados UnidosFil: Dai, Xiangguo. Henry Ford Hospital; Estados UnidosFil: Janic, Branislava. Henry Ford Hospital; Estados UnidosFil: Liu, Yun He. Henry Ford Hospital; Estados UnidosFil: Yang, Xiao Ping. Henry Ford Hospital; Estados UnidosFil: Carretero, Oscar A.. Henry Ford Hospital; Estados UnidosAmerican Physiological Society2016-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/86090González, Germán Esteban; Rhaleb, N.-E.; D'Ambrosio, Martin A.; Nakagawa, Pablo; Liao, Tang Dong; et al.; Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension; American Physiological Society; American Journal of Physiology - Heart and Circulatory Physiology; 311; 5; 11-2016; H1287-H12960363-6135CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1152/ajpheart.00096.2016info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130499/info:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpheart.00096.2016?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmedinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:51:31Zoai:ri.conicet.gov.ar:11336/86090instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:51:31.535CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
title |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
spellingShingle |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension González, Germán Esteban ANGIOTENSIN II FIBROSIS GALECTIN-3 HYPERTENSION INFLAMMATION INTERLEUKIN-6 MACROPHAGES |
title_short |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
title_full |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
title_fullStr |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
title_full_unstemmed |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
title_sort |
Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension |
dc.creator.none.fl_str_mv |
González, Germán Esteban Rhaleb, N.-E. D'Ambrosio, Martin A. Nakagawa, Pablo Liao, Tang Dong Peterson, Edward L. Leung, Pablo Dai, Xiangguo Janic, Branislava Liu, Yun He Yang, Xiao Ping Carretero, Oscar A. |
author |
González, Germán Esteban |
author_facet |
González, Germán Esteban Rhaleb, N.-E. D'Ambrosio, Martin A. Nakagawa, Pablo Liao, Tang Dong Peterson, Edward L. Leung, Pablo Dai, Xiangguo Janic, Branislava Liu, Yun He Yang, Xiao Ping Carretero, Oscar A. |
author_role |
author |
author2 |
Rhaleb, N.-E. D'Ambrosio, Martin A. Nakagawa, Pablo Liao, Tang Dong Peterson, Edward L. Leung, Pablo Dai, Xiangguo Janic, Branislava Liu, Yun He Yang, Xiao Ping Carretero, Oscar A. |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
ANGIOTENSIN II FIBROSIS GALECTIN-3 HYPERTENSION INFLAMMATION INTERLEUKIN-6 MACROPHAGES |
topic |
ANGIOTENSIN II FIBROSIS GALECTIN-3 HYPERTENSION INFLAMMATION INTERLEUKIN-6 MACROPHAGES |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Galectin- 3 (Gal-3), a member of the β-galactoside lectin family, has an important role in immune regulation. In hypertensive rats and heart failure patients, Gal-3 is considered a marker for an unfavorable prognosis. Nevertheless, the role and mechanism of Gal-3 action in hypertension-induced target organ damage are unknown. We hypothesized that, in angiotensin II (ANG II)-induced hypertension, genetic deletion of Gal-3 prevents left ventricular (LV) adverse remodeling and LV dysfunction by reducing the innate immune responses and myocardial fibrosis. To induce hypertension, male C57BL/6J and Gal-3 knockout (KO) mice were infused with ANG II (3 µg·min-1·kg-1 sc) for 8 wk. We assessed: 1) systolic blood pressure by plethysmography, 2) LV function and remodeling by echocardiography, 3) myocardial fibrosis by histology, 4) cardiac CD68+ macrophage infiltration by histology, 5) ICAM-1 and VCAM-1 expression by Western blotting, 6) plasma cytokines, including interleukin- 6 (IL-6), by enzyme-linked immunosorbent assay, and 7) regulatory T (Treg) cells by flow cytometry as detected by their combined expression of CD4, CD25, and FOXP3. Systolic blood pressure and cardiac hypertrophy increased similarly in both mouse strains when infused with ANG II. However, hypertensive C57BL/6J mice suffered impaired ejection and shortening fractions. In these mice, the extent of myocardial fibrosis and macrophage infiltration was greater in histological sections, and cardiac ICAM-1, as well as plasma IL-6, expression was higher as assessed by Western blotting. However, all these parameters were blunted in Gal-3 KO mice. Hypertensive Gal-3 KO mice also had a higher number of splenic Treg lymphocytes. In conclusion, in ANG II-induced hypertension, genetic deletion of Gal-3 prevented LV dysfunction without affecting blood pressure or LV hypertrophy. This study indicates that the ANG II effects are, in part, mediated or triggered by Gal-3 together with the related intercellular signaling (ICAM-1 and IL-6), leading to cardiac inflammation and fibrosis. Fil: González, Germán Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Henry Ford Hospital; Estados Unidos Fil: Rhaleb, N.-E.. Henry Ford Hospital; Estados Unidos. Wayne State University; Estados Unidos Fil: D'Ambrosio, Martin A.. Henry Ford Hospital; Estados Unidos Fil: Nakagawa, Pablo. Henry Ford Hospital; Estados Unidos Fil: Liao, Tang Dong. Henry Ford Hospital; Estados Unidos Fil: Peterson, Edward L.. Henry Ford Hospital; Estados Unidos Fil: Leung, Pablo. Henry Ford Hospital; Estados Unidos Fil: Dai, Xiangguo. Henry Ford Hospital; Estados Unidos Fil: Janic, Branislava. Henry Ford Hospital; Estados Unidos Fil: Liu, Yun He. Henry Ford Hospital; Estados Unidos Fil: Yang, Xiao Ping. Henry Ford Hospital; Estados Unidos Fil: Carretero, Oscar A.. Henry Ford Hospital; Estados Unidos |
description |
Galectin- 3 (Gal-3), a member of the β-galactoside lectin family, has an important role in immune regulation. In hypertensive rats and heart failure patients, Gal-3 is considered a marker for an unfavorable prognosis. Nevertheless, the role and mechanism of Gal-3 action in hypertension-induced target organ damage are unknown. We hypothesized that, in angiotensin II (ANG II)-induced hypertension, genetic deletion of Gal-3 prevents left ventricular (LV) adverse remodeling and LV dysfunction by reducing the innate immune responses and myocardial fibrosis. To induce hypertension, male C57BL/6J and Gal-3 knockout (KO) mice were infused with ANG II (3 µg·min-1·kg-1 sc) for 8 wk. We assessed: 1) systolic blood pressure by plethysmography, 2) LV function and remodeling by echocardiography, 3) myocardial fibrosis by histology, 4) cardiac CD68+ macrophage infiltration by histology, 5) ICAM-1 and VCAM-1 expression by Western blotting, 6) plasma cytokines, including interleukin- 6 (IL-6), by enzyme-linked immunosorbent assay, and 7) regulatory T (Treg) cells by flow cytometry as detected by their combined expression of CD4, CD25, and FOXP3. Systolic blood pressure and cardiac hypertrophy increased similarly in both mouse strains when infused with ANG II. However, hypertensive C57BL/6J mice suffered impaired ejection and shortening fractions. In these mice, the extent of myocardial fibrosis and macrophage infiltration was greater in histological sections, and cardiac ICAM-1, as well as plasma IL-6, expression was higher as assessed by Western blotting. However, all these parameters were blunted in Gal-3 KO mice. Hypertensive Gal-3 KO mice also had a higher number of splenic Treg lymphocytes. In conclusion, in ANG II-induced hypertension, genetic deletion of Gal-3 prevented LV dysfunction without affecting blood pressure or LV hypertrophy. This study indicates that the ANG II effects are, in part, mediated or triggered by Gal-3 together with the related intercellular signaling (ICAM-1 and IL-6), leading to cardiac inflammation and fibrosis. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/86090 González, Germán Esteban; Rhaleb, N.-E.; D'Ambrosio, Martin A.; Nakagawa, Pablo; Liao, Tang Dong; et al.; Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension; American Physiological Society; American Journal of Physiology - Heart and Circulatory Physiology; 311; 5; 11-2016; H1287-H1296 0363-6135 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/86090 |
identifier_str_mv |
González, Germán Esteban; Rhaleb, N.-E.; D'Ambrosio, Martin A.; Nakagawa, Pablo; Liao, Tang Dong; et al.; Cardiac-deleterious role of galectin-3 in chronic Angiotensin II-induced hypertension; American Physiological Society; American Journal of Physiology - Heart and Circulatory Physiology; 311; 5; 11-2016; H1287-H1296 0363-6135 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpheart.00096.2016 info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130499/ info:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpheart.00096.2016?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
dc.publisher.none.fl_str_mv |
American Physiological Society |
publisher.none.fl_str_mv |
American Physiological Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269099516755968 |
score |
13.13397 |